000 | 01914 a2200577 4500 | ||
---|---|---|---|
005 | 20250514042858.0 | ||
264 | 0 | _c20021003 | |
008 | 200210s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAttoub, Samir | |
245 | 0 | 0 |
_aThe c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. _h[electronic resource] |
260 |
_bCancer research _cSep 2002 |
||
300 |
_a4879-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aChick Embryo |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-kit _xbiosynthesis |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aStem Cell Factor _xantagonists & inhibitors |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aRivat, Christine | |
700 | 1 | _aRodrigues, Sylvie | |
700 | 1 | _aVan Bocxlaer, Saskia | |
700 | 1 | _aBedin, Monique | |
700 | 1 | _aBruyneel, Erik | |
700 | 1 | _aLouvet, Christophe | |
700 | 1 | _aKornprobst, Michel | |
700 | 1 | _aAndré, Thierry | |
700 | 1 | _aMareel, Marc | |
700 | 1 | _aMester, Jan | |
700 | 1 | _aGespach, Christian | |
773 | 0 |
_tCancer research _gvol. 62 _gno. 17 _gp. 4879-83 |
|
999 |
_c12089652 _d12089652 |